Prevention of diseases caused by Staphylococcus aureus using the peptide RIP
- 1 September 2000
- Vol. 21 (9) , 1301-1311
- https://doi.org/10.1016/s0196-9781(00)00272-2
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Activation and Inhibition of the Staphylococcal AGR SystemScience, 2000
- Shift-down in growth rate rather than high cell density induces toxic shock syndrome toxin-1 gene expression inStaphylococcus aureusFEMS Microbiology Letters, 1999
- The role of environmental factors in the regulation of virulence-determinant expression in Staphylococcus aureus 8325-4Microbiology, 1998
- Hypervariable Epitope Constructs Representing Variability in Envelope Glycoprotein of SIV Induce a Broad Humoral Immune Response in Rabbits and Rhesus MacaquesAIDS Research and Human Retroviruses, 1998
- Molecular Interactions between Two Global Regulators, sar and agr, in Staphylococcus aureusJournal of Biological Chemistry, 1998
- Clinical and molecular aspects of the pathogenesis of Staphylococcus aureus bone and joint infectionsJournal of Medical Microbiology, 1996
- Pharmacokinetic Considerations in the Treatment of Bacterial KeratitisClinical Pharmacokinetics, 1994
- OsteomyelitisCurrent Opinion in Rheumatology, 1994
- Virulence factors involved in the pathogenesis of bovine intramammary infections due to Staphylococcus aureusJournal of Medical Microbiology, 1994
- Outbreak of spontaneous staphylococcal arthritis and osteitis in miceArthritis & Rheumatism, 1990